MedPath

Study of effectiveness of propofol dosage in prevention of nausa and vomiting in some surgeris

Phase 3
Conditions
Condition 1: Nausea. Condition 2: Vomit.
Registration Number
IRCT20160307026950N21
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
48
Inclusion Criteria

The person should not have received any sedative or narcotic drugs
No gastrointestinal problems such as reflux
Patients should be between 18 and 65 years old.
Having a informed consent to enter the research

Exclusion Criteria

If there is any change in the relaxation method and the change in the surgical method, the patient should be excluded from the study.
The patient's age is more than 65 years
The patient's age is less than 18 years

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ausea score based on VAS criteria. Timepoint: During recovery time after surgery. Method of measurement: questionnaire.;To vomit or not to vomit. Timepoint: During recovery time after surgery. Method of measurement: questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath